t-cells

Documents about t-cells

• XCR1+ and CD11b+ migratory dendritic cells cooperate for the cross-priming of intratumoral CD8+ T cells with a tissue-resident memory phenotype#13844Europe PMC
• Synthesis of Immunotoxin of Anti-CD3 Monoclonal Antibody-Bongkrekic Acid and Cytotoxic Effect Against CD3+ T Cells in Peripheral Blood Mononuclear Cells.#481020NCBI PubMed Central
• Loss of SHP-1 in CD11c cells impairs anti-tumor immunity.#686643Repisalud
• CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma#834525ClinicalTrials.gov
• Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research#855864ClinicalTrials.gov
• Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma#841981ClinicalTrials.gov
• A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors#884433ClinicalTrials.gov
• CAR-T-19 Cells for Patients With CD19+ Relapse/Refractory B-ALL#886949ClinicalTrials.gov
• Linperlisib Combined With Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma#1032446ClinicalTrials.gov
• Comprehensive analysis of immune-related genes reveals diagnostic biomarkers and molecular subtypes in diabetic retinopathy#123679PLOS
• Clonal expansion of CAR-T cells harboring lentivector integration in the PLAAT4 gene following anti-CD19 CAR T-cell therapy in a context of cutaneous T-cell lymphoma#342177HAL (France)
• A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma#880565ClinicalTrials.gov
• Successful Use of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy with Lisocabtagene Maraleucel in a Renal Transplant Recipient with Refractory/Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)#219205ODU Digital Commons
• Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin#137382HAL (France)
• IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody for Recurrent Malignant Glioma#181776ClinicalTrials.gov
• Engineering CAR-Vδ2 T cells to boost persistence and anti-tumor function#183336bioRxiv / medRxiv
• The neurotoxic legacy of CAR-T cells: where do we stand?#196050NCBI PubMed Central
• Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors#234305bioRxiv / medRxiv
• AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma#238108ClinicalTrials.gov
• Meningeal T-cells in the cross-talk between memory consolidation and sleep#265842Repositorio USS
• CD1a-Mediated Presentation of Canonical Microbial Peptides to T Cells#266268bioRxiv / medRxiv
• Aged circulating CD8(+) T cells and their secreted factors drive cognitive decline.#288611NCBI PubMed Central
• CD8(+) T cell differentiation into NK-like effector cells drives transplant rejection.#295207NCBI PubMed Central
• CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia#356486ClinicalTrials.gov
• Follow the “DOTs”: Vδ1(+) γδ T cells as effectors of cancer immunotherapy#360966PubMed Central
• Human airway epithelial cells express a functional IL‐5 receptor#383930CiNii
• Red Blood Cells as Endogenous Biotweezers for Optical Micromanipulation In Vivo.#399810NCBI PubMed Central
• TIGAR coordinates polyol and glutamine metabolism to regulate CD4+ T cells#629522Europe PMC
• Investigating Naïve CD8+ T Cells’ Heterogeneity in Early Life#681161UR Research
• Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients#875096ClinicalTrials.gov
• Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma#888971ClinicalTrials.gov
• A Study of Armored CAR T Cells in People With Cancer#896111ClinicalTrials.gov
• A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer#994893ClinicalTrials.gov
• Activation of Intestinal Type 3 Innate Lymphoid Cells and Regulatory T Cells Through Free Fatty Acid Receptor 2 Ameliorates Type 1 Diabetes in Mice#241994IBISS
• Activation of Intestinal Type 3 Innate Lymphoid Cells and Regulatory T Cells Through Free Fatty Acid Receptor 2 Ameliorates Type 1 Diabetes in Mice#241995IBISS
• Extracellular vesicles from glycolytic mesenchymal stromal cells restrain arthritis progression via IL-10–Producing T and B cells#274304HAL (France)
• CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma.#140998ClinicalTrials.gov
• MSLN-targeted CAR-T Cells in Solid Tumors.#824876ClinicalTrials.gov
• CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors#1030391ClinicalTrials.gov
• Influenza vaccine-specific CD4+ T cell responses are impaired in older adults#7750HAL (France)
• Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma#896152ClinicalTrials.gov
• CD19-BCMA Dual Nanobody Based CAR-T Cells for Patients With DSA#873668ClinicalTrials.gov
• Infusion of Allogeneic, 3rd Party CD19-specific T Cells#874036ClinicalTrials.gov
• Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors#915404ClinicalTrials.gov
• Deep exploration of the TCR CDR3β repertoire specific for viral CD4 T-cell epitopes inside the circulating T-cell repertoire#417985HAL (France)
• Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial#432891ClinicalTrials.gov
• PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma#18587ClinicalTrials.gov
• Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients#18809ClinicalTrials.gov
• PBMC Donation in UCAR-T Cells#67865ClinicalTrials.gov
• GLIS3 is a key regulator of astrocyte differentiation in human neural stem cells#151560bioRxiv / medRxiv